Bought
Maintained
Sold
Other funds holding HSP
MCM
Baird's HSP Position: Q1 2015 in Review
Baird reduced its Hospira (HSP) stake by 93% in Q1 2015, selling an estimated $54.3M and leaving 49,912 shares worth $4.38M. The position accounts for 0.04% of the portfolio, ranked #368.
Baird first reported a position in HSP in Q4 2014 and has held it in 2 quarters since. The position peaked at $45.5M in Q4 2014. 490 funds tracked by Wall St. Rank hold HSP as of Q1 2015.
- Baird held 49,912 shares of Hospira worth $4.38M as of Q1 2015.
- Baird sold 692,777 Hospira shares in Q1 2015, an estimated $54.3M.
- Hospira made up 0.04% of Baird's portfolio in Q1 2015, its #368 holding.
- Baird first reported a position in Hospira in Q4 2014 and has held it in 2 quarters since.
- Baird's Hospira position peaked at $45.5M in Q4 2014.
- 490 funds tracked by Wall St. Rank held Hospira as of Q1 2015.
Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.